OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization
Nimrat Khehra, Inderbir Padda, Urooj Jaferi, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 33
Nimrat Khehra, Inderbir Padda, Urooj Jaferi, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
RNA therapeutics: updates and future potential
Caroline Zhang, Biliang Zhang
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 12-30
Open Access | Times Cited: 79
Caroline Zhang, Biliang Zhang
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 12-30
Open Access | Times Cited: 79
The nano delivery systems and applications of mRNA
Mingyuan Li, Yuan Li, Shiqin Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113910-113910
Open Access | Times Cited: 88
Mingyuan Li, Yuan Li, Shiqin Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113910-113910
Open Access | Times Cited: 88
Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
Yongguang Gao, Xinhua Liu, Na Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 178-178
Open Access | Times Cited: 35
Yongguang Gao, Xinhua Liu, Na Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 178-178
Open Access | Times Cited: 35
Oral Vaccines: A Better Future of Immunization
Keith Wai-Yeung Kwong, Ying Xin, Nelson Cheuk-Yin Lai, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1232-1232
Open Access | Times Cited: 26
Keith Wai-Yeung Kwong, Ying Xin, Nelson Cheuk-Yin Lai, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1232-1232
Open Access | Times Cited: 26
The Coronavirus pandemic – 2022: Viruses, variants & vaccines
Magdalini Alexandridi, Julija Mazej, Enrico Palermo, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 1-9
Open Access | Times Cited: 35
Magdalini Alexandridi, Julija Mazej, Enrico Palermo, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 1-9
Open Access | Times Cited: 35
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis
Sara Sadeghi, Yasamin Kalantari, Sima Shokri, et al.
Journal of Clinical Virology (2022) Vol. 153, pp. 105196-105196
Open Access | Times Cited: 32
Sara Sadeghi, Yasamin Kalantari, Sima Shokri, et al.
Journal of Clinical Virology (2022) Vol. 153, pp. 105196-105196
Open Access | Times Cited: 32
Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study
Safi Alqatari, Mona Ismail, Manal Hasan, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 1263-1278
Open Access | Times Cited: 20
Safi Alqatari, Mona Ismail, Manal Hasan, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 1263-1278
Open Access | Times Cited: 20
The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
Miklós Bege, Anikó Borbás
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 909-909
Open Access | Times Cited: 26
Miklós Bege, Anikó Borbás
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 909-909
Open Access | Times Cited: 26
Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications
Rebecca Goldman, Namratha Turuvekere Vittala Murthy, Trent P. Northen, et al.
Biomaterials (2023) Vol. 301, pp. 122243-122243
Open Access | Times Cited: 15
Rebecca Goldman, Namratha Turuvekere Vittala Murthy, Trent P. Northen, et al.
Biomaterials (2023) Vol. 301, pp. 122243-122243
Open Access | Times Cited: 15
A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights
Parham Soufizadeh, Vahid Mansouri, Naser Ahmadbeigi
Laboratory Animal Research (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
Parham Soufizadeh, Vahid Mansouri, Naser Ahmadbeigi
Laboratory Animal Research (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
An update on SARS-CoV-2 immunization and future directions
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review
Soheila Pourmasumi, Alireza Nazari, Zahra Ahmadi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1982-1982
Open Access | Times Cited: 13
Soheila Pourmasumi, Alireza Nazari, Zahra Ahmadi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1982-1982
Open Access | Times Cited: 13
COVID-19 Vaccine Evolution and Beyond
Yardley Brice, Larry Morgan, Maaida Kirmani, et al.
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 7
Yardley Brice, Larry Morgan, Maaida Kirmani, et al.
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 7
Comparative characteristics of COVID-19 vaccines used for mass immunisation
Г. Г. Онищенко, Т. Е. Сизикова, В. Н. Лебедев, et al.
Biological Products Prevention Diagnosis Treatment (2021) Vol. 21, Iss. 3, pp. 158-166
Open Access | Times Cited: 15
Г. Г. Онищенко, Т. Е. Сизикова, В. Н. Лебедев, et al.
Biological Products Prevention Diagnosis Treatment (2021) Vol. 21, Iss. 3, pp. 158-166
Open Access | Times Cited: 15
Nanotechnology-based approaches in the fight against SARS-CoV-2
Alrayan Abass Albaz, Misbahuddin M. Rafeeq, Ziaullah M. Sain, et al.
AIMS Microbiology (2021) Vol. 7, Iss. 4, pp. 368-398
Open Access | Times Cited: 11
Alrayan Abass Albaz, Misbahuddin M. Rafeeq, Ziaullah M. Sain, et al.
AIMS Microbiology (2021) Vol. 7, Iss. 4, pp. 368-398
Open Access | Times Cited: 11
Adverse drug reactions from two COVID-19 vaccines reported in Saudi Arabia
Amjad Alfaleh, Abdullah Alkattan, Nashwa Radwan, et al.
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 2, pp. 84-92
Open Access | Times Cited: 7
Amjad Alfaleh, Abdullah Alkattan, Nashwa Radwan, et al.
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 2, pp. 84-92
Open Access | Times Cited: 7
Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis
Abdulaziz Alhossan, Amjad Khalid Alsaran, Afnan Hussain Almahmudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2089-2089
Open Access | Times Cited: 5
Abdulaziz Alhossan, Amjad Khalid Alsaran, Afnan Hussain Almahmudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2089-2089
Open Access | Times Cited: 5
Immunologic response, Efficacy, and Safety of Vaccines Against COVID-19 Infection in Children and Adolescents Aged 2 – 21 years old: A Systematic Review
Sara Sadeghi, Yasamin Kalantari, Sima Shokri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Sara Sadeghi, Yasamin Kalantari, Sima Shokri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Advances in RNA therapeutics for modulation of ‘undruggable’ targets
Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, et al.
Progress in molecular biology and translational science (2024), pp. 249-294
Closed Access
Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, et al.
Progress in molecular biology and translational science (2024), pp. 249-294
Closed Access
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers
Melda Emin, Dragan Cibrev, Coskun Kerala, et al.
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 3, pp. 377-382
Open Access
Melda Emin, Dragan Cibrev, Coskun Kerala, et al.
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 3, pp. 377-382
Open Access
Nanotechnology based drug delivery systems for malaria
Sedanur Keleş, Jahid Alakbarli, Buşra Akgül, et al.
International Journal of Pharmaceutics (2024), pp. 124746-124746
Closed Access
Sedanur Keleş, Jahid Alakbarli, Buşra Akgül, et al.
International Journal of Pharmaceutics (2024), pp. 124746-124746
Closed Access
Biomaterials in Their Role in Creating New Approaches for the Delivery of Drugs, Proteins, Nucleic Acids, and Mammalian Cells in Safety Pharmacology
L. R. Brown
Springer eBooks (2024), pp. 1145-1171
Closed Access
L. R. Brown
Springer eBooks (2024), pp. 1145-1171
Closed Access
Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications
Yu Chen, Tian Fan, Shunlin Hu, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1932-1932
Open Access
Yu Chen, Tian Fan, Shunlin Hu, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1932-1932
Open Access
Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual
Ling Ni, Fang Ye, Qin Qiao, et al.
National Science Open (2022) Vol. 1, Iss. 1, pp. 20220009-20220009
Open Access | Times Cited: 1
Ling Ni, Fang Ye, Qin Qiao, et al.
National Science Open (2022) Vol. 1, Iss. 1, pp. 20220009-20220009
Open Access | Times Cited: 1
